SCHEMBL4055064

SCHEMBL4055064

Cc1ccc(N2c3ccccc3NS2(=O)=O)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.39
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
ADORA3 P0DMS8 1/20 0.39
SLC6A2 P23975 1/20 0.39
ALDH1A1 P00352 1/20 0.38
OPRL1 P41146 6/20 0.37
TP53 P04637 2/20 0.36
KDM4E B2RXH2 1/20 0.36
RECQL P46063 1/20 0.36
HTT P42858 1/20 0.36
OPRM1 P35372 1/20 0.36
MAPT P10636 1/20 0.36
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
THRB P10828 1/20 0.35
PKM P14618 1/20 0.34
F2 P00734 1/20 0.33
ELANE P08246 1/20 0.33
CTSG P08311 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3596885 0.86 PTPN1 (0.41) SLC6A2OPRL1KDM4ERECQLOPRM1
SCHEMBL3605818 0.83 SLC6A2 (0.38) LMNAGAAHPGDSLC6A2ALDH1A1
SCHEMBL3608555 0.83 SLC6A2 (0.38) LMNASLC6A2OPRL1KDM4ERECQL
SCHEMBL4064047 0.83 HTT (0.42) LMNAGAAHPGDSLC6A2ALDH1A1
SCHEMBL4059648 0.83 SLC6A2 (0.42) LMNAGAAHPGDSLC6A2ALDH1A1
SCHEMBL4057197 0.81 ALDH1A1 (0.40) LMNAGAAHPGDALDH1A1KDM4E
SCHEMBL3600126 0.79 MGLL (0.39) HPGDSLC6A2ALDH1A1OPRL1KDM4E
SCHEMBL4059777 0.78 HSP90AA1 (0.40) GAASLC6A2ALDH1A1OPRL1KDM4E
SCHEMBL3600016 0.77 KDM4E (0.35) LMNASLC6A2ALDH1A1OPRL1KDM4E
SCHEMBL4057100 0.77 GRIN2D (0.37) ADORA3ALDH1A1OPRL1TP53KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2061776-A1 ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE Wyeth a Corporation of the State of Delaware (US) 2009-05-27 EP disclosed
US-20080161366-A1 AMINOALKYL SUBSTITUTED ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE WYETH (US) 2008-07-03 US disclosed
WO-2008073459-A1 ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE WYETH (US) 2008-06-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161366-A1 AMINOALKYL SUBSTITUTED ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE SLC6A4, SLC6A2, SLC6A3 LMNA 3676/4885GAA 525/4885HPGD 2336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.